These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 21963271)

  • 1. [Emerging Acinetobacter baumannii infections and factors favouring their occurrence].
    Eveillard M; Joly-Guillou ML
    Pathol Biol (Paris); 2012 Oct; 60(5):314-9. PubMed ID: 21963271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acinetobacter infection--an emerging threat to human health.
    Visca P; Seifert H; Towner KJ
    IUBMB Life; 2011 Dec; 63(12):1048-54. PubMed ID: 22006724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reservoirs of Acinetobacter baumannii outside the hospital and potential involvement in emerging human community-acquired infections.
    Eveillard M; Kempf M; Belmonte O; Pailhoriès H; Joly-Guillou ML
    Int J Infect Dis; 2013 Oct; 17(10):e802-5. PubMed ID: 23672981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An outbreak of multidrug-resistant Acinetobacter baumannii-calcoaceticus complex infection in the US military health care system associated with military operations in Iraq.
    Scott P; Deye G; Srinivasan A; Murray C; Moran K; Hulten E; Fishbain J; Craft D; Riddell S; Lindler L; Mancuso J; Milstrey E; Bautista CT; Patel J; Ewell A; Hamilton T; Gaddy C; Tenney M; Christopher G; Petersen K; Endy T; Petruccelli B
    Clin Infect Dis; 2007 Jun; 44(12):1577-84. PubMed ID: 17516401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acinetobacter baumannii: an emerging multidrug-resistant threat.
    Gootz TD; Marra A
    Expert Rev Anti Infect Ther; 2008 Jun; 6(3):309-25. PubMed ID: 18588496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Current approaches to explain the virulence of Acinetobacter baumannii].
    Aşık G
    Mikrobiyol Bul; 2011 Apr; 45(2):371-80. PubMed ID: 21644082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acinetobacter in modern warfare.
    O'Shea MK
    Int J Antimicrob Agents; 2012 May; 39(5):363-75. PubMed ID: 22459899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acinetobacter baumannii: an emerging multidrug-resistant pathogen in critical care.
    Montefour K; Frieden J; Hurst S; Helmich C; Headley D; Martin M; Boyle DA
    Crit Care Nurse; 2008 Feb; 28(1):15-25; quiz 26. PubMed ID: 18238934
    [No Abstract]   [Full Text] [Related]  

  • 9. Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic options.
    Kempf M; Rolain JM
    Int J Antimicrob Agents; 2012 Feb; 39(2):105-14. PubMed ID: 22113193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergence and spread of carbapenem-resistant strains of Acinetobacter baumannii in a tertiary-care hospital in Poland.
    Wroblewska MM; Towner KJ; Marchel H; Luczak M
    Clin Microbiol Infect; 2007 May; 13(5):490-6. PubMed ID: 17331123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Multidrug-resistant Acinetobacter baumannii infection in respiratory intensive care unit].
    Bacakoğlu F; Korkmaz Ekren P; Taşbakan MS; Başarik B; Pullukçu H; Aydemir S; Gürgün A; Başoğlu OK
    Mikrobiyol Bul; 2009 Oct; 43(4):575-85. PubMed ID: 20084910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for nosocomial imipenem-resistant Acinetobacter baumannii infections.
    Baran G; Erbay A; Bodur H; Ongürü P; Akinci E; Balaban N; Cevik MA
    Int J Infect Dis; 2008 Jan; 12(1):16-21. PubMed ID: 17513154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colistin and rifampicin in the treatment of multidrug-resistant Acinetobacter baumannii infections.
    Bassetti M; Repetto E; Righi E; Boni S; Diverio M; Molinari MP; Mussap M; Artioli S; Ansaldi F; Durando P; Orengo G; Bobbio Pallavicini F; Viscoli C
    J Antimicrob Chemother; 2008 Feb; 61(2):417-20. PubMed ID: 18174197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Acinetobacter infections.
    Michalopoulos A; Falagas ME
    Expert Opin Pharmacother; 2010 Apr; 11(5):779-88. PubMed ID: 20210684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outbreak of multidrug-resistant Acinetobacter baumannii in a Belgian university hospital after transfer of patients from Greece.
    Wybo I; Blommaert L; De Beer T; Soetens O; De Regt J; Lacor P; Piérard D; Lauwers S
    J Hosp Infect; 2007 Dec; 67(4):374-80. PubMed ID: 18023922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Occurrence of alert pathogens in hospital environment Part II. Multidrug-resistant non-fermenting bacilli].
    Paluchowska P; Skałkowska M; Spelak A; Budak A
    Med Dosw Mikrobiol; 2012; 64(1):45-53. PubMed ID: 22808729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outbreak of nosocomial meningitis caused by Acinetobacter baumannii in neurosurgical patients.
    Wroblewska MM; Dijkshoorn L; Marchel H; van den Barselaar M; Swoboda-Kopec E; van den Broek PJ; Luczak M
    J Hosp Infect; 2004 Aug; 57(4):300-7. PubMed ID: 15262390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nosocomial imipenem-resistant Acinetobacter baumannii infections: epidemiology and risk factors.
    Dizbay M; Tunccan OG; Sezer BE; Hizel K
    Scand J Infect Dis; 2010 Oct; 42(10):741-6. PubMed ID: 20500117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights into acinetobacter war-wound infections, biofilms, and control.
    Dallo SF; Weitao T
    Adv Skin Wound Care; 2010 Apr; 23(4):169-74. PubMed ID: 20299843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for multi-drug resistant Acinetobacter baumannii nosocomial infection.
    Surasarang K; Narksawat K; Danchaivijitr S; Siripanichgon K; Sujirarat D; Rongrungrueng Y; Kiratisin P
    J Med Assoc Thai; 2007 Aug; 90(8):1633-9. PubMed ID: 17926995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.